Determinants and evolution of squamous intraepithelial lesions in HIV-infected women, 1991-2004

被引:4
作者
Drogoul-vey, M-P.
Marimoutou, C.
Robaglia-schlupp, A.
Beerli, M.
Gastaut, J-A.
Cau, P.
Poizot-martin, I.
机构
[1] Hop St Marguerite, Dept Rech Clin, CISIH SUD, F-13009 Marseille, France
[2] Hop Conception, Biol Cellulaire Lab, Marseille, France
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2007年 / 19卷 / 08期
关键词
D O I
10.1080/09540120701295242
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study presents a case-control nested analysis of cervical squamous intraepithelial lesions (SIL) in a cohort of 423 HIV-infected women with registered Pap smears between 1991 and 2004. Data on Pap smear results, CDC HIV classification, CD4 cell count and antiretroviral therapy were prospectively collected. Pap smears were classified using the Bethesda classification. Women had a median of three Pap smears registered in the database. The first Pap smear was registered 51996 for 57.7%. Two hundred and twenty women were diagnosed with SIL at least once, mainly at their first screening. Compared to women free of SIL and cancer at all Pap smear, they were younger, had lower CD4 cell count and were more likely included 51996 and less likely treated with HAART. These differences persisted in multivariate analysis. Among the 142 women with secondary Pap smears after SIL diagnosis, 43 (30.3%) worsen their Pap smear results. No specific characteristics could be identified for these patients compared to those who did not. Finally 21 women were diagnosed with cervix cancer, three at first Pap smear and the others after a previous SIL diagnosis in a median delay of three years. These results reflect the change in gynaecologic management of HIV-infected women after HAART introduction but also underline the necessity to maintain a regular gynaecologic screening for HIV-infected women.
引用
收藏
页码:1052 / 1057
页数:6
相关论文
共 17 条
[1]   Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women [J].
Ahdieh-Grant, L ;
Li, R ;
Levine, AM ;
Massad, LS ;
Strickler, HD ;
Minkoff, H ;
Moxley, M ;
Palefsky, J ;
Sacks, H ;
Burk, RD ;
Gange, SJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (14) :1070-1076
[2]   CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus [J].
Cardillo, M ;
Hagan, R ;
Abadi, J ;
Abadi, MA .
CANCER CYTOPATHOLOGY, 2001, 93 (02) :111-114
[3]   Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy [J].
Clifford, GM ;
Polesel, J ;
Rickenbach, M ;
Dal Maso, L ;
Keiser, O ;
Kofler, A ;
Rapiti, E ;
Levi, F ;
Jundt, G ;
Fisch, T ;
Bordoni, A ;
De Weck, D ;
Franceschi, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :425-432
[4]  
DELFRAISSY JF, 2006, PRISE CHARGE PERSONN
[5]   Cervical squamous intraepithelial lesions in HIV-infected women:: prevalence, incidence and regression [J].
Delmas, MC ;
Larsen, C ;
van Benthem, B ;
Hamers, FF ;
Bergeron, C ;
Poveda, JD ;
Anzén, B ;
van den Hoek, A ;
Meier, F ;
Peña, JM ;
Savonius, H ;
Sperandeo, D ;
Suligoi, B ;
Vernazza, P ;
Brunet, JB ;
De Vincenzi, I .
AIDS, 2000, 14 (12) :1775-1784
[6]   Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998 [J].
Franceschi, S ;
Dal Maso, L ;
Pezzotti, P ;
Polesel, J ;
Braga, C ;
Piselli, P ;
Serraino, D ;
Tagliabue, G ;
Federico, M ;
Ferretti, S ;
De Lisi, V ;
La Rosa, F ;
Conti, E ;
Budroni, M ;
Vicario, G ;
Piffer, S ;
Pannelli, F ;
Giacomin, A ;
Bellù, F ;
Tumino, R ;
Fusco, M ;
Rezza, G .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (01) :84-90
[7]   Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status [J].
Gilles, C ;
Manigart, Y ;
Konopnicki, D ;
Barlow, P ;
Rozenberg, S .
GYNECOLOGIC ONCOLOGY, 2005, 96 (01) :112-118
[8]   Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results [J].
Harris, TG ;
Burk, RD ;
Palefsky, JM ;
Massad, LS ;
Bang, JY ;
Anastos, K ;
Minkoff, H ;
Hall, CB ;
Bacon, MC ;
Levine, AM ;
Watts, DH ;
Silverberg, MJ ;
Xue, XN ;
Melnick, SL ;
Strickler, HD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (12) :1471-1476
[9]   Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections [J].
Hawes, SE ;
Critchlow, CW ;
Niang, MAF ;
Diouf, MB ;
Diop, A ;
Touré, P ;
Kasse, AA ;
Dembele, B ;
Sow, PS ;
Coll-Seck, AM ;
Kuypers, JM ;
Kiviat, NB .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (04) :555-563
[10]  
Heard I, 2004, ANTIVIR THER, V9, P13